Form 4: Alignment Healthcare Director Thomas Carella Acquires 40,000 Restricted Stock Units
SEC Form 4 Filing
Director Thomas J. Carella of Alignment Healthcare, Inc. acquired 40,000 restricted stock units on March 13, 2024.
Summary
- On March 13, 2024, Thomas J. Carella, a director of Alignment Healthcare, Inc., acquired 40,000 restricted stock units.
- These restricted stock units represent the right to receive one share of Alignment Healthcare's common stock each.
- The acquisition was made at a price of $0.00.
- The restricted stock units will vest on the one-year anniversary of the grant date, provided Carella continues to serve as a member of the Board of Directors.
- Following the transaction, Carella directly owns 124,478 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of stock units by a director can be seen as a positive sign, but it's a routine occurrence.
Positives
- The acquisition of restricted stock units by a director signals confidence in the company's future performance.
Future Outlook
The restricted stock units will vest on the one-year anniversary of the grant date, contingent on continued service as a director.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 03/13/2024 | Date of transaction: Thomas Carella acquired 40,000 restricted stock units. |
| 03/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.